A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Volume:
Issue:
Year of Publication: 2022
Statistics
Citations : 2Authors : 0
Identifiers
Doi : 10.1186/s12981-022-00446-3SSN :